Related Experiment Video

Updated: May 25, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.6K

An Update on Vaccines Against Trypanosoma cruzi and Chagas Disease

Nisha J Garg1,2

  • 1Department of Microbiology & Immunology, University of Texas Medical Branch (UTMB), Galveston, TX 77555-1070, USA.

Pathogens (Basel, Switzerland)
|February 26, 2025
PubMed

Insights

Chagas disease lacks preventative treatments, driving the need for new immune therapies. This review details current vaccine development efforts against Trypanosoma cruzi, the parasite causing this global health concern.

Area of Science:

  • * Immunology
  • * Infectious Diseases
  • * Tropical Medicine

Background:

  • * Chagas disease (CD) is a significant global health issue caused by *Trypanosoma cruzi*.
  • * Current treatments are limited, especially for prophylaxis in travelers or early-stage infections.
  • * The economic impact of Chagas cardiomyopathy necessitates the development of novel therapies.

Purpose of the Study:

  • * To provide an updated overview of vaccine development strategies against Chagas disease.
  • * To highlight the importance of inducing a Th1 immune response for pathogen clearance.
  • * To underscore the rationale for investing in immune-based interventions for CD.

Main Methods:

  • * Comprehensive literature review of recent advancements in Chagas disease vaccine research.
  • * Analysis of proposed vaccine candidates and their immunological targets.
  • * Evaluation of the role of T-helper 1 (Th1) responses in combating *Trypanosoma cruzi*.

Main Results:

  • * Significant research efforts are underway to develop effective vaccines against Chagas disease.
  • * Vaccine efficacy is strongly linked to the induction of a robust Th1 immune response.
  • * Various vaccine platforms and strategies are being explored to target *T. cruzi*.

Conclusions:

  • * The development of vaccines against Chagas disease is crucial for public health.
  • * Inducing a strong Th1 response is key to successful vaccine efficacy.
  • * Continued investment in immune therapy research is warranted to combat CD.

Keywords:
ChagasTrypanosoma cruzivaccine

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.3K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.1K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
43.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
Cross-reactivity00:42

Cross-reactivity

Overview
30.9K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
531
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.2K